Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma

We report on 59 Hodgkin lymphoma patients undergoing haploidentical stem cell transplantation (SCT; haplo-SCT) with posttransplant cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis, comparing outcomes based on pretransplant exposure to checkpoint inhibitors (CPIs). Considering...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: De Philippis, Chiara, Legrand-Izadifar, Faezeh, Bramanti, Stefania, Giordano, Laura, Montes de Oca, Catalina, Duléry, Rémy, Bouabdallah, Reda, Granata, Angela, Devillier, Raynier, Mariotti, Jacopo, Sarina, Barbara, Harbi, Samia, Maisano, Valerio, Furst, Sabine, Pagliardini, Thomas, Weiller, Pierre-Jean, Lemarie, Claude, Calmels, Boris, Chabannon, Christian, Santoro, Armando, Mohty, Mohamad, Blaise, Didier, Castagna, Luca
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160255/
https://ncbi.nlm.nih.gov/pubmed/32227210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019001336
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars